FDA approves Amtagavi for treatment of Advanced melanoma Dr. Kamal Kant Kohli22 Feb 2024 7:00 PM ISTThe US Food and Drug Administration has approved first cellular therapy Amtagavi for treatment of Advanced melanoma. It is one-time cell therapy for...
USFDA accepts for priority review Bristol Myers Squibb application for Krazati, cetuximab combo for colorectal cancer Ruchika Sharma22 Feb 2024 1:30 PM ISTNew York: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental...
Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review Ruchika Sharma22 Feb 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
JnJ gets USFDA nod for Bi-weekly dose of blood cancer therapy Tecvayli Ruchika Sharma21 Feb 2024 11:39 AM ISTUnited States: The U.S. Food and Drug Administration has approved a bi-weekly dose of Johnson & Johnson's blood cancer therapy Tecvayli, the...
New research offers hope to those affected by aggressive brain cancer Anshika Mishra20 Feb 2024 9:15 AM ISTNew research from the University of Sussex holds promise for extending life expectancy and enhancing treatment options for a common and aggressive...
Taxane-based chemotherapy in Asian breast cancer patients tied to skin changes, hair loss: Study Medha Baranwal20 Feb 2024 7:00 AM ISTSouth Korea: A recent study published in The Journal of Dermatology evaluated the effects of treatment regimens in Asian breast cancer (BC)...
Can breast cancer be detected through spit test? Dr. Kamal Kant Kohli19 Feb 2024 11:15 PM ISTScientists have developed a saliva test that screens for breast cancer, which is showing promising results in experimental testing, according to a...
AstraZeneca-Daiichi Sankyo application for Datopotamab deruxtecan accepted in US for patients with previously treated advanced nonsquamous non-small cell lung cancer Ruchika Sharma19 Feb 2024 4:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...
Moderate or severe traumatic brain injury tied to subsequent development of brain cancer in young veterans: JAMA Medha Baranwal19 Feb 2024 5:45 AM ISTUSA: A cohort study of more than 1.9 million veterans of the Afghanistan and Iraq wars showed that traumatic brain injury (TBI) is associated with the...
Gilead Sciences pauses enrollment globally in magrolimab solid tumor studies Ruchika Sharma17 Feb 2024 2:43 PM ISTFoster City: Gilead Sciences, Inc. has announced that it has paused enrollment globally in the magrolimab solid tumor studies. The U.S. Food and Drug...
AstraZeneca Tagrisso with chemotherapy approved in US for EGFR-mutated advanced lung cancer Ruchika Sharma17 Feb 2024 12:00 PM ISTTagrisso (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against CNS metastases.
Age not a contraindication for microvascular reconstruction of advanced oral cancer Dr. Shravani Dali17 Feb 2024 6:30 AM ISTAge is not a contraindication for microvascular reconstruction of advanced oral cancer suggests a new study published in the Oral Surgery, Oral...
